Our team in India are celebrating the just announced partnership with Sun Pharma, India’s top pharmaceutical company and the world’s 4th largest speciality generic pharma business.
This is hard work and Wavemaker smarts: I’m certain our strong insights and precision capabilities will positively provoke growth for Sun Pharma
Ajay gupte, wavemaker south asia CEO
Sun Pharma has grown to become India’s largest and most valuable pharmaceutical company by market capitalisation with global revenues of over US$ 4 billion. Sun Pharma’s global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities.